Shamis, Sharel – Trademark Portfolio

Entity Type: 01

Shamis, Sharel has 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include PURRVANA. The portfolio includes 1 registered trademark. Filings span 3 Nice Classification classes, led by Class 20 (Furniture) and Class 21 (Housewares). This trademark owner is based in Haifa.

Wingate 13

Haifa 3353302 , IL

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PURRVANA
PURRVANA
Abandoned 2024
PURRVANA
PURRVANA
Registered 2024
ROSEWORK
ROSEWORK
Cancelled 2019

Trademark Classifications

Shamis, Sharel's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

20
Furniture (1 filing)

Furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker

21
Housewares (1 filing)

Household or kitchen utensils and containers; combs and sponges; brushes

16
Paper Goods (1 filing)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

Frequently Asked Questions

How many trademarks does Shamis, Sharel have?

Shamis, Sharel has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 1 cancelled.

What trademark classes does Shamis, Sharel file in?

Shamis, Sharel files trademarks across 3 Nice Classification classes. The most active classes are Class 20 (Furniture), Class 21 (Housewares), Class 16 (Paper Goods). Class 20 covers furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker.

What are Shamis, Sharel's most well-known trademarks?

Shamis, Sharel's registered trademark portfolio includes well-known marks such as PURRVANA. These are among 1 currently registered trademark in the portfolio.

What is Shamis, Sharel's trademark registration success rate?

Shamis, Sharel has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.